https://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/wavelet-aims-to-transform-fetal-heart-monitoring-with-ai-non-invasive-eeg-tech-M6LF7PPDTNFL7JBIIYK5R5U7CA/2026-04-14T22:27:27.295Zalways0.5Insightsen2026-04-14T22:27:27.295Zhttps://insights.citeline.com/resizer/F8WZn8KsQueNoj4yDCYp89-6X88=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3AOEZIAM6ZEI7PSKG4HERNQVXU.jpeghttps://insights.citeline.com/pink-sheet/market-access/pricing-debate/us-tariffs-to-hit-european-pharmaceutical-smes-disproportionately-WZ7BIP63JBEJBHJQHCHNAFINWQ/2026-04-14T22:23:13.051Zalways0.5Insightsen2026-04-14T22:23:13.051Zhttps://insights.citeline.com/resizer/PuOSZTn4nx7kx99cSbzyeSQufXk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HWRZT7M7VBC2XECXP45PQSJCIU.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/us-fda-to-clarify-plausible-mechanism-framework-with-genome-editing-guidances-workshop-QTWKR3NCXJFJNKCOE3BTBSW4K4/2026-04-14T22:22:35.388Zalways0.5Insightsen2026-04-14T22:22:35.388Zhttps://insights.citeline.com/resizer/JmgCxLoAFoidgW_s_gvFPWfl9A4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WMOWKU4ATBEK3CEZW4JNUEC2VQ.jpghttps://insights.citeline.com/pink-sheet/drug-safety/ema-aligns-with-us-on-severe-liver-injury-warning-for-angelinis-ontozry-BHFFZLK6ZVHNXCMPPBDCLBK7ZI/2026-04-14T22:21:58.484Zalways0.5Insightsen2026-04-14T22:21:58.484Zhttps://insights.citeline.com/resizer/AVva8ixcYfNsHjn3SRgi8gcCAiE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y4DPXOBM65CNHDHLVM5SBVP5YU.jpghttps://insights.citeline.com/pink-sheet/compliance/marketing-and-advertising/does-fda-untitled-letter-for-adcetris-facebook-ads-signal-start-of-social-media-crackdown-IOK6SCYIWRC23B7XBEDWQLWBP4/2026-04-14T22:21:02.433Zalways0.5Insightsen2026-04-14T22:21:02.433Zhttps://insights.citeline.com/resizer/YiK41OWaB00ud-62vN8KrxfLovM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZAEWXLJ7GBDSZDIAUHM74SHRVA.jpghttps://insights.citeline.com/pink-sheet/rare-diseases/us-fdas-literature-based-leucovorin-approval-may-offer-a-rare-disease-template-Z34IYMFF35ENVJXV4N4ZT4GG6Q/2026-04-14T22:20:37.631Zalways0.5Insightsen2026-04-14T22:20:37.631Zhttps://insights.citeline.com/resizer/2fI8u5cRbcjja51drwkJWDUhRyg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HVD4SJONQRBYJG54VSUTN56WZU.jpghttps://insights.citeline.com/scrip/the-2026-scrip-awards-is-open-for-entries-DM6HGII7MNFX3NJ3PDESDHDGSU/2026-04-14T22:07:34.985Zalways0.5Insightsen2026-04-14T22:07:34.985Zhttps://insights.citeline.com/resizer/ZPcC8vH-vUw3z7Q8t2YNPGkrug4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GQLLZB72ONBQVFIJ4CILSCOQRM.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/spyre-sees-monotherapy-potential-for-uc-drug-after-phase-ii-data-POSGUSO6IZC3HD4OSYDU5IWR3Q/2026-04-14T22:06:26.996Zalways0.5Insightsen2026-04-14T22:06:26.996Zhttps://insights.citeline.com/resizer/VmZsI3iVHbYivcR757QtrabSK7g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/64SNVG7NFZC63K4YZXORJZPRKQ.jpghttps://insights.citeline.com/scrip/new-products/traveres-filspari-is-first-drug-approved-for-fsgs-NVRT4F7TH5FK5DAQZY3VU7IA5Y/2026-04-14T22:05:56.95Zalways0.5Insightsen2026-04-14T22:05:56.95Zhttps://insights.citeline.com/resizer/7S3m5pZEBDQ7-tGeGOEse6jTm0M=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IIPBZVSUAFHPDBSIVTDHFYFP6Q.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/evommune-makes-case-for-mrgprx2-inhibition-in-migraine-JZEKIIVFKRAWDBAP5JYRPL57Z4/2026-04-14T22:05:38.229Zalways0.5Insightsen2026-04-14T22:05:38.229Zhttps://insights.citeline.com/resizer/ARYLZj2IF6D1sPrQ_JqSuIASKKo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4JTBXT3S4FHZJG7BXA4PGBIOCE.jpghttps://insights.citeline.com/scrip/business/deals/eli-lilly-to-buy-crossbridge-and-its-dual-payload-adc-tech-SPF66FDCPFH6XF23EXJKSENSCE/2026-04-14T22:04:37.936Zalways0.5Insightsen2026-04-14T22:04:37.936Zhttps://insights.citeline.com/resizer/Tv1vcBRo_sbt6d7GGlsz4tyb1iM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CN7RA4TYANDVHEHIVZ4II24N4E.jpeghttps://insights.citeline.com/scrip/business/deals/obsidian-will-go-public-via-merger-with-galera-and-raise-350m-MPJVJNBZPNHB5DSSJIM5OILYAQ/2026-04-14T22:03:47.05Zalways0.5Insightsen2026-04-14T22:03:47.05Zhttps://insights.citeline.com/resizer/qh6gER82nuKjE--9pvCOJAwwbPw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HZFIVJVUJBNWPMM2TQI776W5F4.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/great-expectations-icotyde-could-be-jjs-biggest-product-ever-duato-says-PCYLIL3YJVAXNPD75ZKK4MUCFU/2026-04-14T22:02:51.848Zalways0.5Insightsen2026-04-14T22:02:51.848Zhttps://insights.citeline.com/resizer/MYYItsznC4JnscEHvfYQ3-iFsmg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LKD45CUNPZEQDPKHHZT6X3Z7HA.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/legal/ftc-false-and-misleading-income-claims-net-catches-another-health-and-wellness-direct-seller-NHKCN4CRXJEXJAC3MIKERWYWEY/2026-04-14T22:01:34.964Zalways0.5Insightsen2026-04-14T22:01:34.964Zhttps://insights.citeline.com/resizer/3L9VN9nZ7M00MSefS7wXQhlS9l8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7PU3HBQENNCRXGXQX3G2GBNU6U.jpghttps://insights.citeline.com/medtech-insight/device-area/orthopedics/cms-looks-to-expand-cjr-model-along-with-rate-bump-in-latest-proposed-rule-E2EFFYPKWZDXRLLAYD6YZI3T74/2026-04-14T20:49:18.567Zalways0.5Insightsen2026-04-14T20:49:18.567Zhttps://insights.citeline.com/resizer/BD_KVSvX9zVH4VhDOJbkf-jRdY0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XHVLWYAZMBEFVNX2DE2LVXUYPM.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/fda-budget-request-reflects-1b-planned-cdrh-spending-MQTLELQGXJGZTKRALQVJNNBZQQ/2026-04-14T19:57:02.135Zalways0.5Insightsen2026-04-14T19:57:02.135Zhttps://insights.citeline.com/resizer/eAtJiR-drkQPxk9xehxcG5l3qhg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QOFKUTERFBFLDFVOJ6LQUHSVJY.jpghttps://insights.citeline.com/generics-bulletin/leadership/interviews/scale-matters-and-portfolio-matters-biocons-erick-on-the-us-biosimilars-market-JFAMEA6GPND5JKN2AC2P57IWRA/2026-04-14T16:05:50.501Zalways0.5Insightsen2026-04-14T16:05:50.501Zhttps://insights.citeline.com/resizer/wmwu_2k6xreszEVVMt4NzWqQmFE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MSCJ33CQJRAHPBEWN5VSPXBPBY.jpghttps://insights.citeline.com/medtech-insight/business/strategy/click-therapeutics-cuts-over-25-of-staff-after-50m-raise-ct-155-commercial-shift-LZH63JQ3UREU3FX74V32GUE3XE/2026-04-14T15:46:20.982Zalways0.5Insightsen2026-04-14T15:46:20.982Zhttps://insights.citeline.com/resizer/Qn7I4rEKrq1MQJU0pV05Zp-zSVc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OO7VRXMD7BJ75ARZV5QNMLD3YU.jpghttps://insights.citeline.com/generics-bulletin/products/generics/ofev-rivals-hit-us-as-five-firms-get-fda-nod-JKMCINNFH5B7BJNOFYP3R4CGMU/2026-04-14T15:43:05.211Zalways0.5Insightsen2026-04-14T15:43:05.211Zhttps://insights.citeline.com/resizer/uMTq6tjXeJdAG94PhRtykXyQIRw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7MM3ZZBEDVGEFI2QPWWCCNCHSE.jpghttps://insights.citeline.com/generics-bulletin/legalandip/organon-clears-legal-overhang-in-crowded-denosumab-market-S6VILMHEWNDENMZF4OULYQIS2M/2026-04-14T15:38:58.629Zalways0.5Insightsen2026-04-14T15:38:58.629Zhttps://insights.citeline.com/resizer/4991eBVjbf-ZDNw_JHUTPxZWVj8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4FQPLMHLAZAHXCJ6M6QZVXLUUQ.jpghttps://insights.citeline.com/in-vivo/podcasts/podcast-how-lilly-tunelab-is-breaking-data-silos-in-biotech-ZP2ZM33GRBG6ZDI6Q4WAWZ4U6Q/2026-04-14T15:35:16.661Zalways0.5Insightsen2026-04-14T15:35:16.661Zhttps://insights.citeline.com/resizer/ZRS16ILQ0j4uuhBNksV741SfUWI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I775OILYCVCTFNEIV7IFDNKQQI.pnghttps://insights.citeline.com/in-vivo/leadership/rising-leaders/in-vivos-2026-rising-leaders-at-a-glance-2S7BIEWE4JD75JKTCLJY3KZXJU/2026-04-14T14:55:30.974Zalways0.5Insightsen2026-04-14T14:55:30.974Zhttps://insights.citeline.com/resizer/qUL2KwheSy8OVGjzwegnRzV2440=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UPM263F335AMNDWRUYECR4FGZI.pnghttps://insights.citeline.com/in-vivo/leadership/in-vivos-2026-rising-leaders-P65JE4EAZ5CDDAW4ABFKNABFKY/2026-04-14T14:29:41.004Zalways0.5Insightsen2026-04-14T14:29:41.004Zhttps://insights.citeline.com/resizer/Bkq1T_WCg0g9lUN8trx1sIzkICE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6UBHVQ6UNVE6LL54ST7GOKUATI.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/regulatory-alignment-helps-cereno-chart-faster-cheaper-route-for-cs014-75YO7UNP5FA4DPP54P3NIC424Y/2026-04-14T14:15:31.06Zalways0.5Insightsen2026-04-14T14:15:31.06Zhttps://insights.citeline.com/resizer/rDfSBceC5__HKb7xn-HiPsmM7rc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BPF36KNULJMB3PWKXMB3WLQSJM.jpghttps://insights.citeline.com/in-vivo/rising-leaders-helping-eu-device-innovators-clear-the-green-agendas-hurdles-4E7ORM5MVNDPJP6WCK6FQZPYDI/2026-04-14T12:14:41.508Zalways0.5Insightsen2026-04-14T12:14:41.508Zhttps://insights.citeline.com/resizer/k1EQzVLI6KbKulZs34HLHR3rqK4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Z4FAK2ZITNAZVAATSF3BJT2NFU.jpghttps://insights.citeline.com/in-vivo/leadership/rising-leaders/rising-leaders-2026-christina-coughlins-pioneering-immuno-oncology-career-2QYSTENFXJHYTNAPVB52D4MSHU/2026-04-14T12:11:45.528Zalways0.5Insightsen2026-04-14T12:11:45.528Zhttps://insights.citeline.com/resizer/R-1CE_qBmxNmxFLTjvG8TlkEzfg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JK6HAGTATZNRRLNFAVIMIBPJCU.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/henlius-challenges-roches-phesgo-with-first-patient-dosed-ZE6Q6Z6RIRCBPK5I24GLUTYL7E/2026-04-14T11:25:03.911Zalways0.5Insightsen2026-04-14T11:25:03.911Zhttps://insights.citeline.com/resizer/22N4Wt3grokIpC5Z1mWfiTliAgY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OAJP2ZC4BNJMLHG5E76KBFHKSA.jpghttps://insights.citeline.com/in-vivo/factors-driving-change-for-medtechs-and-biotechs-a-legal-view-PSH3OA3FGBEHVBXQ32OAEI2ZA4/2026-04-14T10:00:13.647Zalways0.5Insightsen2026-04-14T10:00:13.647Zhttps://insights.citeline.com/resizer/U9tiHZo-TpnrVWg3JKTqVYU14b0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/T7RQZQAQDRPYLB7KTPQS5PEVVU.jpghttps://insights.citeline.com/hbw-insight/health/business/how-much-growth-is-left-in-otc-SGZYXVKRC5DIXAUK5YQX6T5VU4/2026-04-14T09:08:48.257Zalways0.5Insightsen2026-04-14T09:08:48.257Zhttps://insights.citeline.com/resizer/rBb9pVB3cnENtCXOgv06-iVqx38=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7BEVDBWVCBC57MHKQJRVKQW7KA.jpeghttps://insights.citeline.com/hbw-insight/leadership/interviews/serving-billions-not-just-selling-products-bayers-consumer-health-strategy-CYKUT6OSRBESFEEHPCWMUNJ5E4/2026-04-14T09:03:16.89Zalways0.5Insightsen2026-04-14T09:03:16.89Zhttps://insights.citeline.com/resizer/XkV2aP8wqv5xqrmyavIIGuk3qSI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6DP77GHGH5DJHC75SVSIKTEGPI.jpghttps://insights.citeline.com/scrip/business/deals/belief-biomeds-deal-making-playbook-for-chinese-rare-disease-drugs-HX2U47IH5ZBF5PVPZ3M3ZZCARU/2026-04-14T08:57:46.658Zalways0.5Insightsen2026-04-14T08:57:46.658Zhttps://insights.citeline.com/resizer/PrVoqCUHZnkHeTl6HLLZ1ag-zgg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5JBWZLCVIVGKVLYS4LKYFHQWFM.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/synox-charts-market-path-for-emactuzumab-after-phase-iii-tgct-win-GOSP26BH3RCJJCGMQM5KGWAQUI/2026-04-14T08:50:04.761Zalways0.5Insightsen2026-04-14T08:50:04.761Zhttps://insights.citeline.com/resizer/aSIdYD_L1i6l6z3ZMVEDzVNkk0U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DEXIXBY5EVATBLELUTKBKNM5MM.jpghttps://insights.citeline.com/in-vivo/deal-making/deals-in-depth-february-2026-T3T3Z5T5HZBGBL6TRHK3A34IYI/2026-04-14T06:08:39.692Zalways0.5Insightsen2026-04-14T06:08:39.692Zhttps://insights.citeline.com/resizer/PEO64Zrfh6lvnNdD2r0ZLC64Gxc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YC5R6SOOQFJPND5YYDIAIBX6VI.pnghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/legal/storm-of-interest-could-follow-ftc-complaint-alleging-false-income-claims-by-mlm-distributor-3JESEYP6XVB5HONE7K7AAXEHAI/2026-04-14T03:54:53.798Zalways0.5Insightsen2026-04-14T03:54:53.798Zhttps://insights.citeline.com/resizer/XdjANw8uj-L_UTo6PG47Y0LKQEc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/F4NYYZQ5F5AXRINHUS7VSPWCFE.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/ai/china-launches-nationwide-plan-for-ai-assisted-drug-regulation-BARVROXCQFC2HBUOQFCKUF3F5A/2026-04-14T03:09:30.789Zalways0.5Insightsen2026-04-14T03:09:30.789Zhttps://insights.citeline.com/resizer/04IKv6RcLoWaGDL0B7vUHJ4FdJ0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XPQNR3ASZBERZHBZZD6RMLGJ6E.jpghttps://insights.citeline.com/pink-sheet/market-access/more-tariff-uncertainty-for-chinese-companies-with-us-fda-approved-drugs-ZY3GAZ7G4RBJLL6OKGZDDRNMFM/2026-04-14T00:54:40.485Zalways0.5Insightsen2026-04-14T00:54:40.485Zhttps://insights.citeline.com/resizer/FknOHA5wX_kn9aCiLfQI2SoRG7w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ACL6F7AJ6BDBPJA2C42HVJI3YM.jpghttps://insights.citeline.com/pink-sheet/market-access/iran-war-how-companies-can-mitigate-higher-costs-and-supply-chain-disruption-ZR2QHCR52VHHJDRWKAK5ZUR5AU/2026-04-14T00:54:02.563Zalways0.5Insightsen2026-04-14T00:54:02.563Zhttps://insights.citeline.com/resizer/Kl-qBrxikXCN9ASSHCBNkaMPJQ4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XAZIO6SL6BCS7BBSXLGMOHALUI.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-cder-cber-continue-hiring-staff-but-more-continue-to-leave-SINLZWBNJVHJTCSSGISFCQKJUA/2026-04-14T00:53:05.509Zalways0.5Insightsen2026-04-14T00:53:05.509Zhttps://insights.citeline.com/resizer/8arE8fY7t4H-OAXRBopps8zgI04=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AL45W5QT6NBVDMQGH5HQ5FGBZI.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/us-fda/new-cber-director-candidate-could-signal-industry-cred-important-again-ZDJ4ECR4QNDBPBRTKNHD2B5R24/2026-04-14T00:52:49.999Zalways0.5Insightsen2026-04-14T00:52:49.999Zhttps://insights.citeline.com/resizer/xKKFm70TG-In1Pshs2SMvQeGnrE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OJXHSWXTKFDENBFK4S5WFSPUXY.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/us-fda-wants-sponsors-to-offer-real-plans-for-pediatric-cellgene-therapy-trials-XZK5QK6NJRHTXC6U7Y4HKO34RI/2026-04-14T00:52:29.824Zalways0.5Insightsen2026-04-14T00:52:29.824Zhttps://insights.citeline.com/resizer/JZp8mBZAsu_8OCQl8tPN5jrbNSA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUKQUJGY4NCILDIOOEKMSMRLOI.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/us-fda/tidmarsh-creates-more-instability-and-uncertainty-for-us-fda-industry-DODHAMVW5REBPPHBUUJHV6PZTU/2026-04-14T00:25:05.908Zalways0.5Insightsen2026-04-14T00:25:05.908Zhttps://insights.citeline.com/resizer/flkmMVzklICm4klbRvySPJ3jKAA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7BORDO57RVDRXKGPRRC3P4MGII.jpghttps://insights.citeline.com/companies/simnova-biotherapeutics2026-04-14T00:05:21.851Zalways0.5Insightsen2026-04-14T00:05:21.851Zhttps://insights.citeline.com/companies/shanghai-curegene-pharmaceutical-co-ltd2026-04-14T00:05:15.667Zalways0.5Insightsen2026-04-14T00:05:15.667Zhttps://insights.citeline.com/companies/noramco-inc2026-04-14T00:05:09.617Zalways0.5Insightsen2026-04-14T00:05:09.617Zhttps://insights.citeline.com/companies/chengdu-kanghong-biotechnology-co-ltd2026-04-14T00:05:03.407Zalways0.5Insightsen2026-04-14T00:05:03.407Zhttps://insights.citeline.com/companies/xelitemed2026-04-14T00:04:57.641Zalways0.5Insightsen2026-04-14T00:04:57.641Zhttps://insights.citeline.com/companies/preat-corporation2026-04-14T00:04:51.346Zalways0.5Insightsen2026-04-14T00:04:51.346Zhttps://insights.citeline.com/companies/sealed-air2026-04-14T00:04:45.529Zalways0.5Insightsen2026-04-14T00:04:45.529Zhttps://insights.citeline.com/companies/epibiotech-co-ltd2026-04-14T00:04:39.263Zalways0.5Insightsen2026-04-14T00:04:39.263Zhttps://insights.citeline.com/companies/mdco-technology-company-limited2026-04-14T00:04:27.368Zalways0.5Insightsen2026-04-14T00:04:27.368Zhttps://insights.citeline.com/companies/liberate-bio-inc2026-04-14T00:04:21.523Zalways0.5Insightsen2026-04-14T00:04:21.523Zhttps://insights.citeline.com/companies/dilon-technologies-inc2026-04-14T00:04:15.256Zalways0.5Insightsen2026-04-14T00:04:15.256Zhttps://insights.citeline.com/companies/shanghai-hutchison-pharmaceuticals-co-ltd2026-04-14T00:04:09.534Zalways0.5Insightsen2026-04-14T00:04:09.534Zhttps://insights.citeline.com/companies/exero-medical2026-04-14T00:04:03.206Zalways0.5Insightsen2026-04-14T00:04:03.206Zhttps://insights.citeline.com/companies/cspc-pharmaceutical-group-limited2026-04-14T00:03:24.19Zalways0.5Insightsen2026-04-14T00:03:24.19Zhttps://insights.citeline.com/companies/national-jewish-health2026-04-14T00:03:12.076Zalways0.5Insightsen2026-04-14T00:03:12.076Zhttps://insights.citeline.com/companies/bioxytran-inc2026-04-14T00:03:00.154Zalways0.5Insightsen2026-04-14T00:03:00.154Zhttps://insights.citeline.com/companies/edwards-lifesciences-corp2026-04-14T00:02:48.024Zalways0.5Insightsen2026-04-14T00:02:48.024Zhttps://insights.citeline.com/companies/griffith-university2026-04-14T00:02:35.966Zalways0.5Insightsen2026-04-14T00:02:35.966Zhttps://insights.citeline.com/companies/stratus-medical-llc2026-04-14T00:02:23.944Zalways0.5Insightsen2026-04-14T00:02:23.944Zhttps://insights.citeline.com/companies/spinogenix2026-04-14T00:02:00.126Zalways0.5Insightsen2026-04-14T00:02:00.126Zhttps://insights.citeline.com/companies/guangzhou-huaxi-medical-technology-co-ltd2026-04-14T00:01:48.064Zalways0.5Insightsen2026-04-14T00:01:48.064Zhttps://insights.citeline.com/companies/zentiva-group-as2026-04-14T00:01:35.835Zalways0.5Insightsen2026-04-14T00:01:35.835Zhttps://insights.citeline.com/companies/otsuka-holdings-co-ltd2026-04-14T00:01:00.4Zalways0.5Insightsen2026-04-14T00:01:00.4Z